Xeris Pharmaceuticals, Inc.

Overview

Xeris Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes innovative solutions that expand the potential of injectable therapeutics. By leveraging unique formulation technology, Xeris aims to improve patient outcomes and access to life-improving treatments.

Therapeutic areas

API / Drug Master Files

Xeris Pharmaceuticals, Inc. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• XRS0104Active2025-06-03

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Xeris Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.